Lupin to present data from Phase 1a trial evaluating LNP7457 at ASCO annual meeting Ruchika Sharma27 May 2025 12:00 PM ISTMumbai: Global pharma major Lupin Limited will present data from its Phase 1a clinical trial evaluating LNP7457, a PRMT5 inhibitor, at the American...
Lupin, SteinCares team up to bring Vision drug Ranibizumab to Latin America Ruchika Sharma26 May 2025 10:30 AM ISTRanibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A.
Lupin collaborate with Honeywell for usage of propellant for inhalers Ruchika Sharma20 May 2025 3:45 PM ISTMumbai: Global pharma major Lupin Limited has announced its plan to use Honeywell's Solstice Air (HFO-1234ze cGMP) propellant to transform respiratory...
Former Coca-Cola executive Punita Lal joins Lupin Board as Additional Director Ruchika Sharma16 May 2025 12:59 PM ISTMumbai: Global pharma major Lupin Limited has appointed Punita Lal as an Additional Director (Non-Executive, Independent) to its Board of ...
Lupin Rivaroxaban Tablets approved by USFDA Ruchika Sharma16 May 2025 12:23 PM ISTMumbai: Global pharma major Lupin Limited has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated...
Lupin introduces kidney disease drug Tolvaptan in US Ruchika Sharma14 May 2025 12:27 PM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Tolvaptan Tablets, 15 mg, 30 mg, 45 mg, 60 mg, and 90 mg in the United States,...
Lupin wins USFDA okay for HIV-1 drug Raltegravir Ruchika Sharma9 May 2025 10:15 AM ISTMumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (USFDA) has approved the Company's...
Lupin unveils partial onset seizures drug Eslicarbazepine Acetate in US Ruchika Sharma8 May 2025 12:01 PM IST Mumbai: Global pharma major Lupin Limited has announced that the company has launched Eslicarbazepine Acetate Tablets, 200 mg, 400 mg, 600...
Revise study protocol: CDSCO Panels tells Lupin on Ranibizumab Solution for Injection 10 mg/mL Dr. Divya Colin30 April 2025 6:00 PM ISTNew Delhi: Responding to the drug major Lupin's proposal to conduct phase IV clinical trial of the ophthalmic drug Ranibizumab Solution for Injection...
Novo Nordisk Withdrawal to Reshape Insulin Market; Lupin's Huminsulin to Gain Spotlight Farhat Nasim24 April 2025 6:29 PM ISTMumbai: Amidst the ongoing news of conventional insulin market disruption and growing concern over potential shortages triggered by Novo...
Lupin gets green light from USFDA for kidney drug Tolvaptan Ruchika Sharma24 April 2025 11:52 AM ISTMumbai: Global pharma major, Lupin Limited, has received approval from the United States Food and Drug Administration (U.S. FDA) for...
Lupin recalls over 2000 bottles of antidepressant medication in US Ruchika Sharma23 April 2025 3:09 PM ISTUS: Lupin Pharmaceuticals Inc, a US-based subsidiary of Mumbai-headquartered Lupin is recalling over 2000 bottles of an antidepressant...
